Phosphatases and tumorigenesis

Current Opinion in Oncology

Volumn 10, Issue 1, 1998, Pages 88-91

  Parsons, Ramon ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN SERINE THREONINE KINASE;

CANCER GENETICS; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; REVIEW;

EID: 0031985674     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199801000-00014     Document Type: Review

References (33)

1. Hunter T: A thousand and one protein kinases. Cell 1987, 50:823-829.
2. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677.
3. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Vogelstein B, Brattain M, et al.: Inactivatlon of type II TGF β receptor in RER+ colon cancers with microsatellite instability. Science 1995, 268:1336-1338.
4. Sun H, Tonks NK, Bar-Sagi D: Inhibition of Ras-induced DNA synthesis by expression of the phosphatase MKP-1. Science 1994, 266:285-288.
5. Sato T, Irie S, Kitada S, Reed JC: FAP-1 : a protein tyrosine phosphatase that associates with Fas. Science 1995, 268:411-415.
6. Bouck N, Bealer N, Shenk T, Berg P, di Mayorca G: New region of the simian virus 40 genome required for efficient viral transformation. Proc Natl Acad Sci U S A 1978, 75:2473-2477.
7. Mungre S, Enderle K, Turk B, Porras A, Wu Y, Mumby M C, Rundell K: Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small t antigen in vitro decrease viral transformation. J Virol 1994, 68:1675-1681.
8. Yang Y, Hearing P, Rundell K: Cellular proteins associated with simian virus 40 early gene products in newly infected cells. J Virol 1979, 32:147-154.
9. Pallas DC, Shahrik LK, Martin BL, Jaspers S, Miller TB, Brautigan DL, Roberts TM: Polyoma small and middle t antigens and sv40 small t antigen form stable complexes with protein phosphatase 2A. Cell 1990, 60:167-176.
10. Rundell K: Complete interaction of cellular 56,000- and 32,000-Mr proteins with simian virus 40 small t antigen in productively infected cells. J Virol 1987, 61:1240-1243.
11. Sontag E, Federov S, Kamibayashi C, Robbins D, Cobb M, Mumby M: The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 1993, 75:887-897.
12. Watanabe G, Howe A, Lee RJ, Albanese C, Shu I, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG: Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A 1996, 93:12861-12866.
13. Wadzinski BE, Wheat WH, Jaspers S, Peruski LFJ, Lickteig RL, Johnson GL, Klemm DJ: Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol Cell Biol 1993, 13:2822-2834.
14. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M, Beach D: CDC25 phosphatases as potential human oncogenes. Science 1995, 269:1575-1577.
15. Gautier J, Solomon MJ, Booher RN, Bazan JF, Kirschner MW: cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell 1991, 67:197-211.
16. Jinno O, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H, Okayama H: Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J 1994, 13:1549-1556.
17. Hoffmann I, Draetta G, Karsenti E: Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylatlon at the G1/S transition. EMBO J 1994, 13:4302-4310.
18. Galaktionov K, Jessus C, Beach D: Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Dev 1995, 9:1046-1058.
19. Galaktionov K, Chen X, Beach D: Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 1996, 382:511-517.
20. Iavarone A, Massague J: Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta In cells lacking the CDK inhibitor p15. Nature 1997, 387:417-422.
21. Nelen MR, Padberg GW, Peeters EAJ, Lin AY, van den Helm B, Frants RR, Coulon V, Goldstein AM, van Reen MMM, Easton DF, et al.: Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996, 13:114-116.
22. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Pue J, Miliaresis C, Rodgers L, McCombie R, et al.: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997, 275:1943-1947.
23. Steck PA, Perhouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, et al.: Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997, 15:356-362.
24. Liaw D, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, et al.: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16:64-67.
25. Marsh DJ, Dahia PLM, Zheng Z, Liaw D, Parsons R, Gorlin RJ, Eng C: Germline mutations in the Cowden disease gene, PTEN, are present in Bannayan-Zonana syndrome. Nat Genet 1997, 16:333-334.
26. Arch EM, Goodman BK, Van Wesep RA, Liaw D, Clarke K, Parsons R, McKusick VA, Geraghty MT: Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 1997, 71:489-493.
27. Tashiro H, Blazes M, Wu R, Cho K, Bose S, Wang Sl, Li J, Parsons R, Hedrick Ellenson L: Mutations in PTEN are frequent in endometrial carcinoma, but rare in other common gynecological malignancies. Cancer Res 1997, 57:3935-3940.
28. Risinger JI, Hayes AK, Berchuck A, Barrett AC: PTEN/MMAC1 mutations in endometrial cancers. Cancer Res 1997, 57:4736-4738.
29. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirken AF, Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997, 57:3660-3663.
30. Wang SI, Pue J, Bruce JN, Cairns P, Sidransky D, Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 1997, 57:4183-4186.
31. Rasheed BKA, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH: PTEN mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 1997, 57:4187-4190.
32. Li D, Sun H: TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor b. Cancer Res 1997, 57:2124-2129.
33. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK: P-TEN, the tumor suppressor from chromosome 10q23, is a dual specificity phosphatase. Proc Natl Acad Sci U S A 1997, 94:9052-9057.